Table 1.

Baseline characteristics of study cohort.

Characteristic	Cohort
Age – median (IQR)	66 (55–74)
Sex – n (%) women	209 (40)
Race
African American or Black– n (%)	103 (19.5)
American Indian or Alaska Nation – n (%)	1 (0.2)
Asian – n (%)	7 (1.3)
Native Hawaiian or Other Pacific Islander– n (%)	2 (0.4)
Other combinations not described – n (%)	179 (33.9)
White – n (%)	119 (22.5)
Declined – n (%)	117 (22.2)
Ethnicity
Not Hispanic or Latino or Spanish origin – n (%)	147 (27.8)
Latino or Spanish origin – n (%)	262 (49.6)
Declined – n (%)	119 (22.5)
Comorbidity
CKD (not ESRD) – n (%)	81 (15.3)
ESRD– n (%)	20 (3.8)
Hypertension– n (%)	334 (63.3)
Diabetes Mellitus – n (%)	204 (38.6)
Asthma– n (%)	41 (7.8)
COPD– n (%)	30 (5.7)
Hyperlipidemia– n (%)	154 (29.2)
History of stroke– n (%)	38 (7.2)
HIV infection– n (%)	14 (2.7)
Heart failure– n (%)	68 (12.9)
Preserved ejection fraction– n (%)	27 (5.1)
Reduced ejection fraction– n (%)	34 (6.4)
Unknown ejection fraction– n (%)	7 (1.3)
CAD– n (%)	74 (14.0)
Obesity (BMI > 30) – n (%)	144 (27.3)
Discharge outcome
Home – n (%)	223 (42.2)
Rehab – n (%)	54 (10.2)
Skilled nursing facility – n (%)	129 (24.4)
Hospice – n (%)	25 (4.7)
Death – n (%)	97 (18.4)
Hospitalization characteristics
Intubated – n (%)	234 (44.3)
Days intubated – median (IQR)	31 (17–44)
Length of stay, days – n (IQR)	19 (7–44)